Search: onr:"swepub:oai:DiVA.org:liu-206636" >
Use of drugs for hy...
Use of drugs for hypertension or heart failure and the risk of death in COVID-19: association with loop-diuretics
-
- Fastbom, Johan (author)
- Natl Board Hlth & Welf Socialstyrelsen, Sweden; Karolinska Inst, Sweden; Stockholm Univ, Sweden
-
- Jonasdottir Bergman, Gudrun (author)
- Natl Board Hlth & Welf Socialstyrelsen, Sweden
-
- Holm, Johanna (author)
- Natl Board Hlth & Welf Socialstyrelsen, Sweden
-
show more...
-
- Hanberger, Håkan (author)
- Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten,Region Östergötland, Infektionskliniken i Östergötland
-
- Stralin, Kristoffer (author)
- Karolinska Univ Hosp, Sweden
-
- Walther, Sten (author)
- Linköpings universitet,Institutionen för hälsa, medicin och vård,Medicinska fakulteten,Region Östergötland, Thorax-kärlkliniken i Östergötland
-
- Alfredsson, Joakim (author)
- Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US
-
- State, Maria (author)
- Natl Board Hlth & Welf Socialstyrelsen, Sweden
-
- Borg, Natalia (author)
- Natl Board Hlth & Welf Socialstyrelsen, Sweden
-
- Nyman Iliadou, Anastasia (author)
- Natl Board Hlth & Welf Socialstyrelsen, Sweden
-
show less...
-
(creator_code:org_t)
- 2024
- 2024
- English.
-
In: European Journal of Clinical Pharmacology. - : SPRINGER HEIDELBERG. - 0031-6970 .- 1432-1041.
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Purpose To study the association between the use of drugs for hypertension or heart failure, particularly diuretics, and risk of death in COVID-19.Methods We conducted a cohort study, based on record linked individual-based data from national registers, of all Swedish inhabitants 50 years and older (n = 3,909,321) at the start of the first SARS-CoV-2 wave in Sweden. The association between use of angiotensin-converting enzyme inhibitors (ACEI), angiotensin II receptor blockers (ARB), thiazides, loop diuretics, aldosterone antagonists, beta blocking agents and calcium channel blockers at the index date 6 March 2020, and death in COVID-19 during 7 March to 31 July 2020, was analysed using Cox-proportional hazards regression, adjusted for a wide range of possible confounders.Results Use of loop diuretics was associated with higher risk [adjusted hazard ratio (HR) 1.26; 95% confidence interval (95% CI) 1.17-1.35] and thiazides with reduced risk (0.78; 0.69-0.88) of death in COVID-19. In addition, lower risk was observed for ACEI and higher risk for beta-blocking agents, although both associations were weak. For ARB, aldosterone antagonists and calcium channel blockers no significant associations were found.Conclusion In this nationwide cohort of nearly 4 million persons 50 years and older, the use of loop diuretics was associated with increased risk of death in COVID-19 during the first SARS-CoV-2 wave in Sweden. This contrasted to the decreased risk observed for thiazides. As treatment with loop diuretics is common, particularly in the elderly, the group most affected by severe COVID-19, this finding merit further investigation.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Keyword
- COVID-19; Loop diuretics; Thiazide diuretics; Angiotensin-converting enzyme inhibitors
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database